Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial

作者：Hubert H Fernandez, Perminder Bhatia, L P Cloud, Urban M. Fietzek, Michele Matarazzo, Eric Molho, E S Peckham, Arjun Tarakad, Cari Combs, Matthew Leoni, Ih Chang, Stacey Tringali, Joey Boiser, Raymond Sanchez, Cindy Zadikoff · 发表于：The Lancet Neurology · 年份：2026 · DOI：10.1016/s1474-4422(26)00215-2 · 被引用次数：3 · 研究领域：Parkinson's Disease Mechanisms and Treatments、Voice and Speech Disorders、Parkinson's Disease and Spinal Disorders